Today’s episode is hosted by Alex Robinson and they are joined on the podcast by Parag Naithani, Head of Statistical Programming at LEO Pharma A/S, Siddhant Prabhu, Senior Director, Head of FounData at Novo Nordisk A/S, Trygvi Laksafoss, Director, Data and AI at Hemab Therapeutics.

The conversation explores how organisations can drive innovation in regulated industries, particularly across pharmaceutical research, healthcare technology and data-driven operations. It considers the balance between meeting strict regulatory requirements and encouraging creative thinking, new approaches and continuous improvement in complex business environments.

The exchange highlights the importance of data governance, digital transformation and emerging technologies in supporting responsible innovation. It also examines broader challenges around regulatory compliance, collaboration and adapting processes while maintaining quality, safety and accountability. For professionals working in pharmaceuticals, life sciences and healthcare data, the discussion offers useful context on building an innovation-focused culture without compromising essential standards. It provides a broader perspective on how organisations can approach pharmaceutical innovation and respond to evolving technological and regulatory demands.